1. The Future of Patient-Derived Tumor Xenografts in Cancer Treatment
   Daniela Sia et al, 2015, Pharmacogenomics CrossRef
2. Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts
   Cheng-Jeng Tai et al, 2017, Clinical and Experimental Medicine CrossRef
3. Concluding Remarks
   Domenico Ribatti, 2018, Judah Folkman CrossRef
4. Bevacizumab Efficacy Is Influenced by Primary Tumor Resection in First-Line Treatment of Metastatic Colorectal Cancer in a Retrospective Multicenter Study
   Mathilde Cabart et al, 2016, Clinical Colorectal Cancer CrossRef
5. Tumor Biology and Natural History
   Daniele Fanale et al, 2021, Practical Medical Oncology Textbook CrossRef
6. Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor
   Hyang Sook Seol et al, 2014, Cancer Letters CrossRef
7. Cancer Clonal Evolution and Intra-tumor Heterogeneity
   Daniele Fanale et al, 2017, Liquid Biopsy in Cancer Patients CrossRef
8. Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo
   Shan Lu et al, 2018, MedChemComm CrossRef
9. Exosomal lncRNA PVT1/VEGFA Axis Promotes Colon Cancer Metastasis and Stemness by Downregulation of Tumor Suppressor miR-152-3p
   Shiue-Wei Lai et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
10. Combined Treatment Strategies for Microtubule Stabilizing Agent-Resistant Tumors
    Angela Broggini-Tenzer et al, 2015, JNCI: Journal of the National Cancer Institute CrossRef
11. A minimum core outcome dataset for the reporting of preclinical chemotherapeutic drug studies: Lessons learned from multiple discordant methodologies in the setting of colorectal cancer
    M.A. West et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
12. Current and Future Horizons of Patient-Derived Xenograft Models in Colorectal Cancer Translational Research
    null Inoue et al, 2019, Cancers CrossRef
13. Preclinical Imaging in Oncology: Considerations and Recommendations for the Imaging Scientist
    Daniel P. Bradley et al, 2014, Pharmaco-Imaging in Drug and Biologics Development CrossRef
14. Antiangiogenic Therapies: Going beyond Their Limits
    Lidia Moserle et al, 2014, Cancer Discovery CrossRef
15. Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection
    N. Miyoshi et al, 2016, ESMO Open CrossRef
16. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer
    Shan Lu et al, 2018, Bioorganic & Medicinal Chemistry Letters CrossRef
17. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review
    Kai M. Brown et al, 2016, Oncotarget CrossRef
18. Current status and perspectives of patient-derived xenograft models in cancer research
    Yunxin Lai et al, 2017, Journal of Hematology & Oncology CrossRef
19. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
    P Ramos et al, 2015, Oncogene CrossRef
20. One mouse, one patient paradigm: New avatars of personalized cancer therapy
    Prerna Malaney et al, 2014, Cancer Letters CrossRef